Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Activity and Messenger Ribonucleic Acid Levels Are Associated with Adiposity and Insulinemia in Pima Indians and Caucasians
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Metabolic effects of cortisol may be critically modulated by glucocorticoid metabolism in tissues. Specifically, active cortisol is regenerated from inactive cortisone by the enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11-HSD1) in adipose and liver. We examined activity and mRNA levels of 11-HSD1 and tissue cortisol and cortisone levels in sc adipose tissue biopsies from 12 Caucasian (7 males and 5 females) and 19 Pima Indian (10 males and 9 females) nondiabetic subjects aged 28 +/- 7.6 yr (mean +/- SD; range, 18-45). Adipose 11-HSD1 activity and mRNA levels were highly correlated (r = 0.51, P = 0.003). Adipose 11-HSD1 activity was positively related to measures of total (body mass index, percentage body fat) and central (waist circumference) adiposity (P < 0.05 for all) and fasting glucose (r = 0.43, P = 0.02), insulin (r = 0.60, P = 0.0005), and insulin resistance by the homeostasis model (r = 0.70, P < 0.0001) but did not differ between sexes or ethnic groups. Intra-adipose cortisol was positively associated with fasting insulin (r = 0.37, P = 0.04) but was not significantly correlated with 11-HSD1 mRNA or activity or with other metabolic variables. In this cross-sectional study, higher adipose 11-HSD1 activity is associated with features of the metabolic syndrome. Our data support the hypothesis that increased regeneration of cortisol in adipose tissue influences metabolic sequelae of human obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This differential effect was largely related to the impact on β-cell function11,138.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
In the citing paper
“Whereas the onset of glucose lowering with the other two medications was slower, it was most sustained with rosiglitazone, with metformin demonstrating an intermediate pattern.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
In the citing paper
“Glibenclamide produced the greatest initial reduction in glycaemia, but was poorest in maintaining glucose control.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Rosmond, R., Dallman, M. F., & Björntorp, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4843 · Cited by 871
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
The role of TNFα and TNF receptors in obesity and insulin resistance
Hotamisligil, G. S. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00490.x · Cited by 780 · cited 1×
“46 Fasting insulin (mU/liter) 45 [38–52] 38 [32–51] 0.”
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Self-citationTissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655
Self-citationPhillips, D. I. W., Barker, D. J. P., Fall, C. H. D., Seckl, J. R., Whorwood, C. B., Wood, P. J., & Walker, B. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4634 · Cited by 596
Rosmond, R. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1853 · Cited by 590
Research works printed but not linked: 1
- 1985, Diabetes mellitus
Cited by
Items 101–200 of 224
Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Paterson, J. M., Seckl, J. R., & Mullins, J. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00017.2005 · Cited by 50
“Intriguingly, obese humans and monogenic obesity models in rodents also show elevated 11 -HSD1 activity and mRNA levels in adipose tissue (31, 43, 67, 70, 71).”
BackgroundDube, S., Norby, B. J., Pattan, V., Carter, R. E., Basu, A., & Basu, R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3017 · Cited by 39
Stimson, R. H., & Walker, B. R. (2013) · hmbci · doi:10.1515/hmbci-2013-0015 · Cited by 38
“In some of these studies, mRNA levels correlated with markers of the metabolic syndrome such as insulin resistance [43, 44].”
Self-citation11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 47
Virtual screening applications in short-chain dehydrogenase/reductase research
Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 40
Brief review: Glucocorticoid excretion in obesity
Müssig, K., Remer, T., & Maser-Gluth, C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.008 · Cited by 36
López-Alvarenga, J. C., Ebbesson, S. O. E., Ebbesson, L. O. E., Tejero, M. E., Voruganti, V. S., & Comuzzie, A. G. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.010 · Cited by 41
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Bavaresco, A., Mazzeo, P., Lazzara, M., & Barbot, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116137 · Cited by 45
Durán-González, J., Ortiz, I., Gonzales, E., Ruiz, N., Ortiz, M., Gonzalez, A., Sanchez, E. K., Curet, E., Fisher‐Hoch, S. P., Rentfro, A. R., et al. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.10.010 · Cited by 40
“Recent evidence suggests that even if circulating levels of glucocorticoids are not elevated, excessive production of glucocorticoids in peripheral tissues is associated with obesity and insulin resistance (43,44) The enzyme 11 beta hydroxysteroid dehydrogenase Type 1 (HSD11B1), which converts the inactive cortisone i…”
BackgroundSelf-citationBarat, P., Gayard-Cros, M., Andrew, R., Corcuff, J., Jouret, B., Barthe, N., Perez, P., Germain, C., Tauber, M., Walker, B. R., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.01.029 · Cited by 40
Self-citationSagmeister, M. S., TAYLOR, A. E. R., Fenton, A., Wall, N. A., Chanouzas, D., Nightingale, P., Ferro, C. J., Arlt, W., Cockwell, P., Hardy, R., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13889 · Cited by 40
Santos, E. G., Salvatori, R., Ferrão, T. D. O., Oliveira, C. R. P., Diniz, R. D. C. A., Santana, J. A. M., Pereira, F. A., Barbosa, R. A. A., Souza, A. H. O., de Melo, E. V., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2132 · Cited by 36
“Local glucocorticoid excess can be generated by the enzymatic conversion of cortisone (E) to cortisol (F) by the 11 -hydroxysteroid dehydrogenase type 1 (11 -HSD-1) enzyme (8, 9), particularly in the liver and adipose tissue (3, 10).”
BackgroundRosiglitazone decreases 11β‐hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue
Mai, K., Andres, J., Bobbert, T., Maser‐Gluth, C., Möhlig, M., Bähr, V., Pfeiffer, A. F. H., Spranger, J., & Diederich, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02903.x · Cited by 36
Genomewide Linkage Analysis of Weight Change in the Framingham Heart Study
Fox, C. S., Heard‐Costa, N. L., Vasan, R. S., Murabito, J. M., D’Agostino, R. B., & Atwood, L. D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1752 · Cited by 33
11β‐Hydroxysteroid Dehydrogenase Type 1 in Obesity
Walker, B. R. (2004) · Obesity Research · doi:10.1038/oby.2004.1 · Cited by 36
Self-citationGlucocorticoids Turn Over Slowly in Human Adipose Tissue in Vivo
Hughes, K. A., Reynolds, R. M., Andrew, R., Critchley, H. O. D., & Walker, B. R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0384 · Cited by 32
Self-citationdo Nascimento, F. V., Piccoli, V., Beer, M. A., von Frankenberg, A. D., Crispim, D., & Gerchman, F. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0036-1 · Cited by 34
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 37
Self-citationTorrecilla, E., Fernández‐Vázquez, G., Vicent, D., Sánchez‐Franco, F., Barabash, A., Cabrerizo, L., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. Á. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0524-9 · Cited by 35
Svendsen, P. F., Madsbad, S., Nilas, L., Paulsen, S. K., & Pedersen, S. B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.165 · Cited by 35
Gambineri, A., Fanelli, F., Tomassoni, F., Munarini, A., Pagotto, U., Andrew, R., Walker, B. R., & Pasquali, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1030 · Cited by 30
Self-citationJang, C., Obeyesekere, V. R., Dilley, R. J., Alford, F. P., & Inder, W. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02669.x · Cited by 30
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status
Clarke, S. A., Eng, P. C., Comninos, A. N., Lazarus, K., Choudhury, S., Tsang, C., Meeran, K. M., Tan, T., Dhillo, W. S., & Abbara, A. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae016 · Cited by 38
Šimonytė, K., Rask, E., Näslund, I., Angelhed, J., Lönn, L., Olsson, T., & Mattsson, C. (2009) · Obesity · doi:10.1038/oby.2009.99 · Cited by 29
“In addition to BMI and BP, insulin resistance has also been reported to be associated with fat accumulation in the SAT of adults and prepubertal children (5,6,17,28).”
BackgroundInfluentialŠimonytė, K., Olsson, T., Näslund, I., Angelhed, J., Lönn, L., Mattsson, C., & Rask, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2472 · Cited by 32
Espíndola-Antunes, D., & Kater, C. E. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800027 · Cited by 33
“Moreover, 11βHSD1 mRNA expression positively correlates with obesity (body mass index and abdominal circumference), body composition, insulin resistance (30-32), resistins and other cytokines, as”
BackgroundDammann, C., Stapelfeld, C., & Maser, E. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.018 · Cited by 30
Liu, J., Wang, L., Zhang, A., Di, W., Zhang, X., Wu, L., Yu, J., Zha, J., Lv, S., Cheng, P., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-318 · Cited by 26
“11β-HSD1 is decreased in liver and enhanced in adipose tissue both in rodent obesity and human obesity [13-23].”
BackgroundVítků, J., Stárka, L., Bičíková, M., Hill, M., Heráček, J., Kolátorová, L., & Hampl, R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.007 · Cited by 29
Al‐Dujaili, E. A. S., Baghdadi, H. H., Howie, F. A., & Mason, J. I. (2012) · Steroids · doi:10.1016/j.steroids.2012.03.001 · Cited by 30
“For example, increased 11bHSD1 activity is implicated in the development of the metabolic syndrome [46,47].”
BackgroundBurén, J., Bergström, S.-A., Loh, E., Söderström, I., Olsson, T., & Mattsson, C. (2007) · Endocrinology · doi:10.1210/en.2006-0897 · Cited by 26
Differences in cortisol concentrations in South Asian and European men living in the United Kingdom
Reynolds, R. M., Fischbacher, C., Bhopal, R. S., Byrne, C. D., White, M., Unwin, N. C., & Walker, B. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02504.x · Cited by 29
Self-citationMapping and association studies of diabetes related genes in the pig
Otieno, C. J., Bastiaansen, J. W. M., Ramos, A. M., & Rothschild, M. F. (2005) · Animal Genetics · doi:10.1111/j.1365-2052.2004.01217.x · Cited by 26
Portal and peripheral cortisol levels in obese humans
Aldhahi, W., Goldfine, A. B., & Mun, E. (2004) · Diabetologia · doi:10.1007/s00125-004-1389-4 · Cited by 28
Drolet, B., Simard, C., & Poirier, P. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00005 · Cited by 23
Sukhija, R., Kakar, P., Mehta, V., & Mehta, J. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.028 · Cited by 25
Koška, J., de Courten, B. V., Wake, D. J., Nair, S., Walker, B. R., Bunt, J. C., Permana, P. A., Lindsay, R. S., & Tataranni, P. A. (2006) · Obesity · doi:10.1038/oby.2006.175 · Cited by 26
“Cortisol and Cortisone Concentrations in Whole AT The infranatant from the RNA extraction protocol (see above) was used to extract steroids (20,23).”
InfluentialSelf-citationMichailidou, Z., Coll, A. P., Kenyon, C. J., Morton, N. M., O’Rahilly, S., Seckl, J. R., & Chapman, K. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0090 · Cited by 27
Esteves, C. L., Kelly, V., Bégay, V., Man, T. Y., Morton, N. M., Leutz, A., Seckl, J. R., & Chapman, K. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037953 · Cited by 26
Methlie, P., Dankel, S. N., Myhra, T. S., Christensen, B. J., Gjerde, J., Fadnes, D. J., Våge, V., Løvås, K., & Mellgren, G. (2013) · Obesity · doi:10.1002/oby.20449 · Cited by 22
“(3) studied 32 overweight subjects, and found that intra-adipose cortisol was positively associated with fasting insulin, but not with BMI or other metabolic parameters.”
BackgroundMethodResultInfluentialMiyamoto, Y., Morisaki, H., Yamanaka, I., Kokubo, Y., Masuzaki, H., Okayama, A., Tomoike, H., Nakao, K., Okamura, T., Yoshimasa, Y., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.05.017 · Cited by 23
Okazaki, S., Takahashi, T., Iwamura, T., Nakaki, J., Sekiya, Y., Yagi, M., Kumagai, H., Sato, M., Sakami, S., Nitta, A., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216556 · Cited by 24
“11b-HSD1 is abundant in the liver and adipose tissue, and higher adipose 11b-HSD1 activity is associated with features of the metabolic syndrome (Lindsay et al., 2003).”
BackgroundAbulizi, A., Camporez, J. P., Zhang, D., Samuel, V. T., Shulman, G. I., & Vatner, D. F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.12.003 · Cited by 22
Calcium-Deficiency during Pregnancy Affects Insulin Resistance in Offspring
Takaya, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137008 · Cited by 25
Atalar, F., Görmez, S., Çaynak, B., Akan, G., Tanrıverdi, G., Gazioglu, S. B., Günay, D., Duran, C., Akpınar, B., Özbek, U., et al. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-115 · Cited by 19
Mlinar, B., Marc, J., Jensterle, M., Bokal, E. V., Jerin, A., & Pfeifer, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.002 · Cited by 24
Woods, C. P., & Tomlinson, J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_16 · Cited by 20
“in 2003 [ 57 ].”
Sex Differences in Body Fat Distribution
Veilleux, A., & Tchernof, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0965-6_5 · Cited by 20
Ku, Y. H., Koo, B. K., Kwak, S. H., Cho, Y. M., Shin, H. D., Lee, H. K., Kim, Y., Choi, J. W., Oh, B., & Park, K. S. (2009) · Hormone Research in Paediatrics · doi:10.1159/000224337 · Cited by 18
Evidence for cortisol–cortisone metabolism by marine mammal blubber
Galligan, T. M., Schwacke, L. H., McFee, W. E., & Boggs, A. S. P. (2018) · Marine Biology · doi:10.1007/s00227-018-3373-4 · Cited by 18
“Notably, we did not expect to observe a reductase reaction (cortisone to cortisol), because previous studies state (but do not demonstrate) that the reductase reaction is not observable in vitro (Livingstone et al. 2000; Rask et al. 2001; Lindsay et al. 2003).”
InfluentialSun, L. Z., Stenken, J. A., Brunner, J. E., Michel, K. B., Adelsberger, J. K., Yang, A. Y., Zhao, J. J., & Musson, D. G. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.06.036 · Cited by 22
Paulsen, S. K., Nielsen, M. P., Richelsen, B., Bruun, J. M., Flyvbjerg, A., & Pedersen, S. B. (2008) · Obesity · doi:10.1038/oby.2008.2 · Cited by 23
“11β-HSD1 expression and activity have been positively associated with measures of obesity, such as BMI (15,27–31), waist circumference (27,32), and volume of visceral AT (33), in most, but not all (34) investigations.”
BackgroundEffects of Gonadectomy on Glucocorticoid Metabolism in Obese Zucker Rats
Barat, P., Livingstone, D. E. W., Elferink, C. M. C., McDonnell, C., Walker, B. R., & Andrew, R. (2007) · Endocrinology · doi:10.1210/en.2007-0597 · Cited by 24
Self-citationGrino, M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00542.2005 · Cited by 17
“Obese patients have increased 11 HSD1 mRNA and activity in subcutaneous adipose tissue, which correlates with several features of the metabolic syndrome such as central adiposity, fasting glucose, insulin, and insulin resistance (12, 14).”
BackgroundAYACHI, S. E., Paulmyer‐Lacroix, O., Verdier, M., Alessi, M., Dutour, A., & Grino, M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01811.x · Cited by 17
Sex Differences in Body Fat Distribution
Mansour, M. F., Chan, C.-W. J., Laforest, S., Veilleux, A., & Tchernof, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-52031-5_8 · Cited by 23
Winnick, J. J., Ramnanan, C. J., Saraswathi, V., Roop, J., Scott, M., Jacobson, P. B., Jung, P. M., Basu, R., Cherrington, A. D., & Edgerton, D. S. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2012 · Cited by 17
11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus
Li, X., Wang, J., Yang, Q., & Shao, S. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.03.023 · Cited by 20
Dujić, T., Bego, T., Mlinar, B., Semiz, S., Malenica, M., Prnjavorac, B., Ostanek, B., Marc, J., & Čaušević, A. (2012) · Biochemia Medica · doi:10.11613/bm.2012.008 · Cited by 19
“Several researches found positive correlations of 11β-HSD1 subcutaneous fat expression with markers of insulin resistance (10,12,14,15,18,19).”
BackgroundInfluentialSharma, M., Vikram, N. K., Misra, A., Bhatt, S., Tarique, M., Parray, H. A., Pandey, R. M., & Luthra, K. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2738-5 · Cited by 24
“An increased expression of 11-bHSD1 m-RNA in abdominal adipocytes was associated with high 11-bHSD1 activity and positively correlated with obesity and plasma insulin concentrations in Pima Indians and Caucasians [12], implicating the role of 11-bHSD1 in the modulation of metabolic diseases.”
BackgroundIs ?Cushing?s disease of the omentum? an affliction of mouse and men?
Walker, B. R. (2004) · Diabetologia · doi:10.1007/s00125-004-1390-y · Cited by 16
Self-citationFujisawa, Y., Nakagawa, Y., Li, R.-S., Liu, Y., & Ohzeki, T. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.002 · Cited by 14
Corticosteroid-dependent hypertension: environmental influences
Odermatt, A. (2004) · Swiss Medical Weekly · doi:10.4414/smw.2004.10372 · Cited by 18
Liu, Y., Sun, W.-L., Sun, Y., Hu, G., & Ding, G. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00316.x · Cited by 14
Sex‐specific Difference in the Interconversion of Cortisol and Cortisone in Men and Women
Vierhapper, H., Heinze, G., & Nowotny, P. (2007) · Obesity · doi:10.1038/oby.2007.592 · Cited by 15
Dineen, R., Martin‐Grace, J., Ahmed, K. M. S., TAYLOR, A. E. R., Shaheen, F., Schiffer, L., Gilligan, L. C., Lavery, G. G., Frizelle, I. M., Gunness, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad370 · Cited by 14
Takaya, J., Yamanouchi, S., & Kaneko, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084125 · Cited by 15
“Whether glucocorticoids modulate Hsd11b1 expression is unknown; hepatic Hsd11b1 expression is very different from that in other tissues [43,44,46].”
BackgroundMai, K., Kullmann, V., Bobbert, T., Maser‐Gluth, C., Möhlig, M., Bähr, V., Pfeiffer, A. F. H., Spranger, J., & Diederich, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02362.x · Cited by 16
Yamamoto, K., Ikeya, T., Okuyama, S., Fukuda, K., & Kobayashi, D. (2021) · Digestive Diseases · doi:10.1159/000514930 · Cited by 12
Mechanisms of androgenic action in adipose tissue
Veilleux, A., & Blouin, K. (2009) · Clinical Lipidology · doi:10.2217/clp.09.16 · Cited by 13
Atalar, F., Görmez, S., Çaynak, B., Akan, G., Tanrıverdi, G., Gazioglu, S. B., Günay, D., Duran, C., Akpınar, B., Özbek, U., et al. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.07.006 · Cited by 13
McCormick, K. L., Wang, X., & Mick, G. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.04.003 · Cited by 12
11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte
Liu, Y., Sun, Y., Zhu, T., Xie, Y., Yu, J., Sun, W.-L., Ding, G., & Hu, G. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00602.x · Cited by 11
Atalar, F., Vural, B., Çiftçi, Ç., Demirkan, A., Akan, G., Duman, B. S., Günay, D., Akpınar, B., Sağbaş, E., Özbek, U., et al. (2012) · Genetics and Molecular Research · doi:10.4238/2012.august.31.10 · Cited by 11
“The level and activity of cortisol, especially in the visceral adipose tissue (VAT) is mainly determined by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1), which is a microsomal short-chain dehydrogenase/reductase; it is bidirectional and converts inactive cortisone to active cortisol (Lindsay et al., 2003).”
BackgroundSex Differences in Energy Balance, Body Composition, and Body Fat Distribution
Tchernof, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_1 · Cited by 13
Itoh, E., Iida, K., Kim, D. S., del Rincon, J. P., Coschigano, K. T., Kopchick, J. J., & Thorner, M. O. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.07.002 · Cited by 10
Psyche and soma: New insights into the connection
Yeragani, V., & Kumar, R. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.69238 · Cited by 13
Morgan, S., Berryman, D. E., List, E. O., Lavery, G. G., Stewart, P. M., & Kopchick, J. J. (2021) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2021.101440 · Cited by 9
Karlsson, C., Jernås, M., Olsson, B., Lystig, T., Gummesson, A., Storlien, L. H., Groop, L., & Carlsson, B. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.009 · Cited by 8
11β-HSD1 Modulates LPS-Induced Innate Immune Responses in Adipocytes by Altering Expression of PTEN
Lai, W., Tian, X., Xiang, Q., Chu, K., Wei, Y., Deng, J., Zhang, S., Brown, J., & Hong, G. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1287 · Cited by 8
Metabolic Syndrome: Is There a Pathophysiological Common Denominator?
Tataranni, P. A. (2005) · KARGER eBooks · doi:10.1159/000088221 · Cited by 8
Self-citationAbdominal circumference should not be a required criterion for the diagnosis of metabolic syndrome
Shibata, K., Suzuki, S., Sato, J., Ohsawa, I., Goto, S., Hashiguchi, M., & Tokudome, S. (2010) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-009-0132-7 · Cited by 8
Gyllenhammer, L. E., Alderete, T. L., Mahurka, S., Allayee, H., & Goran, M. I. (2013) · Obesity · doi:10.1002/oby.20571 · Cited by 6
“There is a large body of evidence in animal and human studies supporting the role of the enzyme 11b-hydroxysteroid dehydrogenase type-1 (11bHSD1) in adipose tissue expansion, glycemic disturbance and cardiometabolic disease (3-8).”
Background11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
Boyle, C. D., Kowalski, T. J., & Zhang, L. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41007-1 · Cited by 7
Koike, T., Shiraki, R., Sasuga, D., Hosaka, M., Kawano, T., Fukudome, H., Kurosawa, K., Moritomo, A., Mimasu, S., Ishii, H., et al. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00211 · Cited by 8
Carbajal, A., Agustí, C., Domingo, M., Olvera-Maneu, S., & López-Béjar, M. (2021) · Marine mammal science · doi:10.1111/mms.12862 · Cited by 6
Devang, N., Nandini, M., Rao, S. B., & Adhikari, P. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0438-5 · Cited by 7
Glucocorticoid receptors in human epicardial adipose tissue: role of coronary status.
Silaghi, C. A., Silaghi, H., Scridon, T., Pais, R., & Achard, V. (2012) · PubMed · doi:10.3275/7969 · Cited by 5
Dujić, T., Ostanek, B., Marc, J., Čaušević, A., & Mlinar, B. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0105 · Cited by 4
Gender‐specific Links Between Hepatic 11β Reduction of Cortisone and Adipokines
Mattsson, C., Rask, E., Carlström, K., Andersson, J. S. O., Eliasson, M., Åhrén, B., Söderberg, S., & Olsson, T. (2007) · Obesity · doi:10.1038/oby.2007.587 · Cited by 7
Differences in Stimulated Androgen Levels in Black and White Obese Adolescent Females
Hannon, T. S., & Arslanian, S. A. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.09.007 · Cited by 4
Ton, H. P. Y. S. H. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000522 · Cited by 5
“In human studies, increase in adipose 11β -HSD1 activity has been constantly found in both subcutaneous and visceral adipose tissues of obese and/or insulinresistant individuals and shows strong correlation to the development of MetS [52,84-89].”
BackgroundObesity and Disease: Insulin Resistance, Diabetes, Metabolic Syndrome and Polycystic Ovary Syndrome
Proietto, J. (2005) · Wiley eBooks · doi:10.1002/9780470987087.ch13 · Cited by 4
Belančić, A., Krpina, M., Majanović, S. K., & Merlak, M. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2019.06.28 · Cited by 4
Boullu‐Ciocca, S., Tassistro, V., Dutour, A., & Grino, M. (2015) · Endocrine · doi:10.1007/s12020-015-0657-z · Cited by 5
Anthrax Lethal Factor Represses Glucocorticoid and Progesterone Receptor Activity
Webster, J. I., Moayeri, M., & Sternberg, E. M. (2006) · Springer eBooks · doi:10.1007/978-0-387-48334-4_4 · Cited by 3
Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter
Andres, J., Mai, K., Möhlig, M., Weickert, M. O., Bumke‐Vogt, C., Diederich, S., Pfeiffer, A. F. H., Bähr, V., & Spranger, J. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701531219 · Cited by 3
“Nevertheless, individuals with a metabolic syndrome were shown to have an increased mRNA-expression and enzyme activity of 11beta-HSD1 within omental or subcutaneous adipose tissue (Lindsay et al., 2003; Engeli et al., 2004; Kannisto et al., 2004; Abdallah et al., 2005; Jang et al., 2006; Mariniello et al., 2006).”
BackgroundPlace de l’axe corticotrope dans le développement de l’obésité abdominale
Barat, P., Duclos, M., Moisan, M., & Mormède, P. (2008) · Archives de Pédiatrie · doi:10.1016/j.arcped.2007.10.022 · Cited by 5
“Ces résultats ont été en partie confirmés chez l’homme : l’activité et l’expression de l’ARNm de la 11ßHSD1 au niveau du tissu adipeux sous-cutané sont positivement corrélées à l’IMC et à l’insulinorésistance chez des sujets obèses [36].”
Diazepane–acetamide derivatives as selective 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Odermatt, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902911490 · Cited by 2
“11β-HSD1 expression and percentage of body fat, waist circumference, fasting glucose and insulin resistance [4, 14-21].”
BackgroundKlusoňová, P., Pátková, L., Ergang, P., Mikšík, I., Zicha, J., Kuneš, J., & Pácha, J. (2011) · Steroids · doi:10.1016/j.steroids.2011.06.003 · Cited by 2
Metadata
- Authors
- Lindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R.
- Affiliations
- National Institutes of Health (US)
- Western General Hospital (GB)
- Corresponding author
- Tataranni, P. Antonio
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2738-2744
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1978718098
- Cited by
- 225
- References
- 42
- Citations by year
- 2024: 2 · 2023: 1 · 2021: 6 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 10 · 2013: 9 · 2012: 10
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, subcutaneous adipose tissue, cortisol, cortisone, adiposity, insulin levels, insulin resistance, metabolic syndrome, obesity, Pima Indians, ethnic differences, gene expression, fasting blood glucose
- MeSH terms
- Adipose Tissue, Adult, Cortisone, Female, Humans, Hydroxysteroid Dehydrogenases, Indians, North American, Insulin, Male, Obesity, RNA, Messenger, Subcutaneous Tissue, 11-beta-Hydroxysteroid Dehydrogenase Type 1, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.